About the Event
Date:November 6–11, 2026
Location:Orlando, FL
Credit:CE: 166.25, ABIM & ABP MOC: 166.25
On Demand:Available
ACR Convergence is an in-person event, showcasing cutting-edge and timely topics in rheumatology, as well as the prevention, diagnosis, and treatment of rheumatic diseases and related comorbid conditions. ACR Convergence offers hundreds of sessions to educate professionals in every segment of rheumatology (on demand pass will also be available). Clinicians, researchers, academicians, practice managers, pediatric rheumatologists, fellows in training, advance practice nurses, physician assistants, physical or occupational therapists: Whatever your role, ACR Convergence is the place to expand your knowledge and skills and pique your curiosity.
Target Audience
Rheumatologists, physicians, physician assistants, nurses, pharmacists, social workers, psychologists and healthcare providers who care for patients with rheumatic diseases, and those interested in or engaged in rheumatology research.
Global Learning Objectives
Upon completion of this activity, participants should be able to:
- Analyze and summarize key clinical principles related to the evaluation, diagnosis, treatment, and counseling of patients with rheumatologic diseases, and communicate these principles across professions to support collaborative clinical decision-making
- Evaluate how advances in basic and clinical science have influenced understanding of established and emerging rheumatologic diseases and integrate these insights into team-based discussions for informed coordinated patient care
- Identify key studies impacting rheumatology and assess their relevance across professional roles
- Identify and engage in networking opportunities to discuss complex clinical cases, exchange research ideas, and establish ongoing professional partnerships that enhance team-based patient outcomes
- Apply evidence and knowledge gained through interprofessional learning activities to enhance collaborative research and team-based patient care, improving quality, safety, and patient-centered outcomes
2025 Meeting Information
If you attended the 2025 meeting, see meeting resources and claim credit in the ACR Education Center.
Program Schedule & Syllabi
ACR Convergence 2026 Online Program
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
Registration Fees
See information about ACR Convergence registration fees and timelines.
Registration Guidelines
Full payment is due at the time of registration.
Cancellations and Refund Request
Please refer to the ACR Convergence 2026 registration page for full cancellation and refund request details.
Hotel & Travel
Press Registration
The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.
See eligibility requirements and request a press pass
Acknowledgement of Commercial Support
To Be Announced
Exhibits and Sponsorships
Support this educational event by becoming an exhibitor or sponsor. Contact Kat Dennis (kdennis@rheumatology.org) with questions and to secure your spot.
Continuing Education (CE)
Accreditation Statement
In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Provider number: 0003797
Designation / Credit Statements
Physicians (ACCME)
The American College of Rheumatology designates this Other Activity (Blended Learning Encompassing Live and On Demand View) for a maximum of 166.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.
For more information, download the AMA PRA Booklet.
Pharmacists (ACPE)
The American College of Rheumatology designates this knowledge-based activity for a maximum of 61.00 hours of ACPE contact hour(s). Pharmacists and pharmacy technicians should claim only the credit commensurate with the extent of their participation in the activity. Universal Activity Number(s): JA0003797-0000-26-022-H99-P.
Credit will be uploaded to the NABP CPE Monitor® within 60 days of activity completion. Because NABP accepts only one credit submission per activity (the conference), you must claim all credits you wish to receive at the same time. Once credits have been submitted, additional credit requests cannot be processed. All continuing pharmacy education credits must be claimed within 60 days of activity completion or attendance.
Per ACPE rules, ACR does not have access nor the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and date of birth (MMDD)) to receive credit.
Nurses (ANCC)
This activity is designated for a maximum of 166.25 ANCC contact hours.
Physician Associates (AAPA)
The American College of Rheumatology has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This other/blended activity is designated for 166.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Social Workers (ASWB ACR)
As a Jointly Accredited Organization, the American College of Rheumatology is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 58.50 general continuing education credits.
See the ACR's CE Mission Statement >
CME & CE credit must be claimed by September 30, 2027, at 11:59 PM ET.
Maintenance of Certification (MOC)
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 166.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC Recognition Statement: American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 166.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying boards above.
MOC points must be claimed by September 30, 2027, at 11:59 PM ET.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CE activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CE activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
ACR Convergence 2026 Financial Relationships Disclosures (to be announced).